Johnson & Johnson
Tracked across 66 events · 2569 articles · First seen Jan 09, 2025 · Last active Aug 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Johnson & Johnson is facing a mass class-action lawsuit in the United Kingdom and ongoing litigation in the United States over allegations that its talc-based products caused cancer due to asbestos contamination. The company has been ordered to pay significant damages in US cases and faces a potential £1 billion liability in the UK.
Oct 16, 2025 · 14 articles
Regulatory
Impact: Johnson & Johnson is being sued by United States — Texas for allegedly hiding Tylenol's risks and deceptively marketing it. The lawsuit also claims Johnson & Johnson fraudulently transferred liabilities to Kenvue.
Oct 28, 2025 · 20 articles
Business
Impact: Johnson & Johnson is investing over $1 billion to expand its Vision operations in United States — Jacksonville, Florida, enhancing its manufacturing, packaging, and distribution capabilities for ACUVUE contact lenses. This investment is part of a larger $55 billion commitment to U.S. manufacturing, research, and development, aiming to strengthen its supply chain and meet growing demand.
Jun 15, 2026 · 12 articles
Regulatory
Impact: As the developer and manufacturer of Guselkumab, Johnson & Johnson benefits from the expanded FDA approval, which enhances the drug's market position and potential sales.
May 28, 2026 · 6 articles
Tech
Impact: Johnson & Johnson developed amivantamab, a revolutionary cancer treatment that has shown unprecedented results in clinical trials, significantly boosting its reputation and potential market share in oncology.
May 30, 2026 · 20 articles
Tech
Impact: The company developed and tested Apalutamide, a prostate cancer drug, which showed significant positive results in late-stage trials, potentially expanding its market and revenue.
May 31, 2026 · 6 articles
Business
Impact: Johnson & Johnson is acquiring Firefly Biotech for $1 billion, expanding its oncology pipeline with the Firelink degrader antibody conjugate platform and preclinical candidates for KRAS-driven tumors. This acquisition strengthens its position in targeted cancer therapies.
Jun 08, 2026 · 13 articles
Regulatory
Impact: Johnson & Johnson is the defendant in the talc litigation; the judge's doubt on causation is favorable for the company, reducing the risk of large verdicts.
Jul 22, 2026 · 6 articles
Regulatory
Impact: J&J received FDA authorization for its OTTAVA robotic system, marking its entry into the US soft-tissue robotic surgery market. This approval is a key milestone for its medtech business and positions it to compete with Intuitive Surgical and Medtronic.
Jul 22, 2026 · 20 articles
Business
Impact: Johnson & Johnson is the defendant proposing the $5.5 billion settlement to resolve most talc lawsuits, which could end a decade-long legal battle and reduce uncertainty.
Jul 27, 2026 · 82 articles
Tech
Impact: Johnson & Johnson>>> is an Assistant Professor at the Terasaki Institute for Biomedical Innovation>>> and a key researcher in the development of the 4-AP gel. His involvement highlights his expertise and contributes to his professional reputation.
Jun 04, 2026 · 6 articles
Business
Impact: Johnson & Johnson is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Jul 28, 2026 · 6 articles
Business
Impact: Key player; growth forecast positive for its medical devices segment.
Jul 21, 2026 · 8 articles
Domestic
Impact: Johnson & Johnson is a U.S. Representative challenging Larry Rhoden in the Republican primary for governor. His participation makes the gubernatorial race highly competitive.
Jun 01, 2026 · 6 articles
Business
Impact: Johnson & Johnson Innovation - JJDC, Inc., Johnson & Johnson's corporate venture capital arm, participated in the Series C financing, indicating its strategic interest in neurological disease treatments and potential future collaborations or acquisitions.
Jun 04, 2026 · 6 articles
Accidents
Impact: Johnson & Johnson Innovative Medicine is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
Business
Impact: Parent company; acquisition demonstrates commitment to orthopedics despite potential sale of Johnson & Johnson — DePuy Synthes.
Jul 16, 2026 · 6 articles
Tech
Impact: Major contributing member; participates in pre-competitive research space.
Jul 13, 2026 · 6 articles
Domestic
Impact: Johnson & Johnson, along with other pharmaceutical companies, had previously announced investments in U.S. production due to the threat of tariffs, but the new, higher tariffs introduce further uncertainty.
Sep 26, 2025 · 7 articles
Domestic
Impact: Johnson & Johnson is a pharmaceutical company that donated to Mikie Sherrill's campaign and also to Jack Ciattarelli's campaign, and reached a settlement for its role in the opioid crisis.
Oct 10, 2025 · 6 articles
Business
Impact: Johnson & Johnson spun off Kenvue two years prior to this acquisition, aiming to make its pharmaceutical and medical device divisions more nimble.
Nov 03, 2025 · 10 articles
Tech
Impact: Johnson & Johnson has invested in AI-powered platforms to enhance decision-making and streamline development processes, reflecting the industry's adoption of intelligent manufacturing.
Apr 07, 2026 · 8 articles
Business
Impact: Johnson & Johnson had a senior talent executive on the panel, indicating its interest in refining HiPo programs and potentially adopting Talogy's recommendations.
Jun 03, 2026 · 6 articles
Business
Impact: Johnson & Johnson, through its subsidiary Johnson & Johnson — Janssen Pharmaceuticals, Inc., is a licensee of ICOTYDE, a drug jointly discovered with AnBogen Therapeutics.
May 28, 2026 · 6 articles
Business
Impact: Johnson & Johnson faces new competition in the treatment-resistant depression market as Lilly's acquisition of Atai Life Sciences positions BPL-003 as a potential rival to J&J's Spravato.
Jul 16, 2026 · 25 articles
Regulatory
Impact: Johnson & Johnson is among companies that have reduced emphasis on diversity in board recruitment, reflecting the broader trend.
Jul 28, 2026 · 6 articles
Tech
Impact: Johnson & Johnson is a researcher at La Trobe University who commented on the study, highlighting the novelty of rapid cell wall changes.
Jun 11, 2026 · 6 articles
International
Impact: Johnson & Johnson, a supply chain consultant, warns that the war's impact on costs will filter through supply chains for the rest of the year, leading to bigger problems if oil shortages persist.
May 05, 2026 · 374 articles
Domestic
Impact: Johnson & Johnson, a Republican Representative, voiced frustration over the current state of Congress, stating that many colleagues have 'forgotten how to govern'.
Jun 29, 2026 · 17 articles
Business
Impact: Johnson & Johnson is the parent company of Johnson & Johnson — Janssen Pharmaceuticals, which is involved in the development and commercialization of ICOTYDE.
Jun 16, 2026 · 6 articles
+ 36 more events
View on Dashboard
10
Johnson & Johnson sent greetings IndiaIndia 80th Independence...
10
Johnson & Johnson said world stronger IndiaIndia 80th Independence...
ERGEN INTELLIGENCE
Track Johnson & Johnson live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard